Literature DB >> 28351695

Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models.

Erenius Toppo1, S Sylvester Darvin1, S Esakkimuthu1, A Stalin1, K Balakrishna1, K Sivasankaran2, P Pandikumar3, S Ignacimuthu4, N A Al-Dhabi5.   

Abstract

The gum of Gardenia resinifera Roth., is one of the important drugs used in the Indian system of medicine and a source of unique polymethoxylated flavones. This study was aimed to evaluate the antihyperlipidemic and anti-NAFLD effects of Gardenin A (Gar-A) from G. resinifera gum using in vitro and in vivo models. Gar-A was isolated from G. resinifera gum and was identified on the basis of the physical and spectral data. Toxicity of Gar-A to HepG2 cells was evaluated using MTT assay. The ability of Gar-A to reduce steatosis was assessed using oleate-palmitate induced HepG2 cell lines by estimating the lipid levels by ORO staining and by estimating the intracellular triglyceride content. Effect of Gar-A on amelioration of lipotoxicity was measured by estimating the LDH levels. The doses for in vivo experiments were fixed by Irwin test, between 50 and 100 mg/kg concentrations, through oral route. The acute antihyperlipidemic effect of Gar-A was assessed in Triton WR-1339 induced hyperlipidemic animals. The chronic antihyperlipidemic and anti-NAFLD effects of Gar-A were evaluated in HFD fed rats. In vitro experiments with HepG2 cell line indicated that the cells treated with Gar-A did not show any significant reduction in the viability up to 70 μg/mL concentration. Steatotic HepG2 cells treated with Gar-A showed a significant reduction in lipid accumulation at 2.5-10 μg/mL concentrations. In triton induced hyperlipidemic rats, the treatment significantly reduced the lipid levels at the synthesis phase. The treatment with Gar-A to the HFD fed animals significantly lowered the steatosis and transaminase levels. The other biochemical parameters such as TC, TG, LDL-c, ALP and ACP were also decreased significantly. Treatment with Gar-A significantly lowered the hyperlipidemia and fat accumulation in the liver; detailed molecular investigations are necessary to establish the antihyperlipidemic and hepatoprotective potentials of Gar-A.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipocyte hypertrophy; FXRα; Fatty Liver; Gardenia lucida; Gardenia resinifera

Mesh:

Substances:

Year:  2017        PMID: 28351695     DOI: 10.1016/j.cbi.2017.03.013

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  3 in total

Review 1.  Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes.

Authors:  Priyanka Saha; Anupam Das Talukdar; Rajat Nath; Satyajit D Sarker; Lutfun Nahar; Jagajjit Sahu; Manabendra Dutta Choudhury
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

2.  Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis.

Authors:  Jiahua Liang; Yingjie Huang; Zhexing Mai; Qunzhang Zhan; Hengchen Lin; Yuxin Xie; Haihao Wang; Yan Liu; Chuanjin Luo
Journal:  Drug Des Devel Ther       Date:  2021-04-30       Impact factor: 4.162

Review 3.  Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects.

Authors:  Ying Hu; Xingjuan Chen; Mu Hu; Dongwei Zhang; Shuo Yuan; Ping Li; Ling Feng
Journal:  Chin Med       Date:  2022-09-29       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.